About: Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1980

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 1980 (fr) наукова стаття, опублікована в лютому 1980 (uk) im Februar 1980 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1980 (ast) scientific article published on 01 February 1980 (en)
publication date	wds:Q71500288-D8A63319-9F2C-4FDD-9C0A-51BADCCAC112
publication date	1980-02-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71500288-52242CA9-236A-4B27-8A02-7C4200CD37BF wds:Q71500288-B92BDE37-AC42-4179-B2E6-9129B0C484B3 wds:Q71500288-D4B01401-2C5D-40ED-B773-46B54109A937
author name string	J J Albers J D Brunzell A Chait
rdfs:label	Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (en) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (nl) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (sq)
skos:prefLabel	Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (en) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (nl) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (sq)
name	Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (en) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (nl) Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (sq)
title	wds:Q71500288-52DD0306-3F3F-4609-A3B0-1845D49C22DA
title	Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia (en)
page(s)	wds:Q71500288-0432C931-0719-4E52-BE46-6AE8DF5AC58E
page(s)	17-22
instance of	wds:Q71500288-E5BB1453-50E2-4CFB-B0AE-789F21E16C29
instance of	scholarly article
PubMed ID	wds:Q71500288-7FEDB8B3-3B50-4012-9B06-056F71CC321D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6768562
PubMed ID	6768562
published in	wds:Q71500288-250B2453-299C-47A7-84AF-9C2C4D7F2073
published in	European Journal of Clinical Investigation
issue	wds:Q71500288-E74616E5-D13C-417D-A602-BD2DBB8271E3
volume	wds:Q71500288-19EB449C-9B41-4467-ACEC-DFBB39D07F24
issue	1
volume	10
DOI	wds:Q71500288-986A54AF-690B-4E2E-B71F-44781A5A72A2
DOI	http://dx.doi.org/10.1111/J.1365-2362.1980.TB00004.X
DOI	10.1111/J.1365-2362.1980.TB00004.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71500288
is cites work of	Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III Dietary therapy of hyperlipidaemia Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man. Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liver The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia Molecular cloning of partial cDNAs for rabbit liver apolipoprotein B and the regulation of its mRNA levels by dietary cholesterol Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects Genetic control of low-density-lipoprotein subclasses Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver Fatty acid composition of the diet: impact on serum lipids and atherosclerosis Genetics of lipoprotein disorders Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls. Water-soluble organosulfur compounds of garlic inhibit fatty acid and triglyceride syntheses in cultured rat hepatocytes Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia Identification of two common variants contributing to serum apolipoprotein B levels in Mexicans Serum apolipoprotein profile of patients with chronic renal failure Effects of HIV protease inhibitor therapy on lipid metabolism Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance Prevalence and expression of familial combined hyperlipidemia in childhood Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B. Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity Single and mixed dyslipidaemia in Canadian primary care settings: findings from the Canadian primary care sentinel surveillance network database Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia Small, Dense LDL and Elevated Apolipoprotein B Are the Common Characteristics for the Three Major Lipid Phenotypes of Familial Combined Hyperlipidemia The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia Concentration of lipid, apoprotein-B and testosterone in patients with coronarographic findings. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment Linkage and association analyses identify a candidate region for apoB level on chromosome 4q32.3 in FCHL families Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept Treatment of common lipoprotein disorders [The apolipoproteins in man ] Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation Genetics of familial combined hyperlipidemia Cholesterol metabolism in familial hypertriglyceridemia: effects of obesity versus triglyceride level. What is Meant by Overproduction of Apo B-Containing Lipoproteins? Atherosclerosis: Pathology, pathogenesis, and role of risk factors Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software